Free Trial

Repay (RPAY) Competitors

Repay logo
$4.59 -0.26 (-5.36%)
Closing price 04:00 PM Eastern
Extended Trading
$4.55 -0.04 (-0.87%)
As of 05:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RPAY vs. VVX, LZ, RAMP, ALIT, FIVN, ACVA, OLO, FLYW, ASTH, and GDRX

Should you be buying Repay stock or one of its competitors? The main competitors of Repay include V2X (VVX), LegalZoom.com (LZ), LiveRamp (RAMP), Alight (ALIT), Five9 (FIVN), ACV Auctions (ACVA), OLO (OLO), Flywire (FLYW), Astrana Health (ASTH), and GoodRx (GDRX). These companies are all part of the "business services" industry.

Repay vs. Its Competitors

V2X (NYSE:VVX) and Repay (NASDAQ:RPAY) are both small-cap business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, earnings, analyst recommendations, valuation and institutional ownership.

In the previous week, V2X had 2 more articles in the media than Repay. MarketBeat recorded 3 mentions for V2X and 1 mentions for Repay. Repay's average media sentiment score of 1.33 beat V2X's score of 0.67 indicating that Repay is being referred to more favorably in the news media.

Company Overall Sentiment
V2X Positive
Repay Positive

V2X currently has a consensus target price of $63.73, indicating a potential upside of 14.25%. Repay has a consensus target price of $7.22, indicating a potential upside of 57.35%. Given Repay's higher probable upside, analysts clearly believe Repay is more favorable than V2X.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
V2X
2 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.62
Repay
1 Sell rating(s)
5 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.30

V2X has a beta of 0.25, indicating that its share price is 75% less volatile than the S&P 500. Comparatively, Repay has a beta of 1.6, indicating that its share price is 60% more volatile than the S&P 500.

95.2% of V2X shares are owned by institutional investors. Comparatively, 82.7% of Repay shares are owned by institutional investors. 1.1% of V2X shares are owned by company insiders. Comparatively, 12.0% of Repay shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

V2X has a net margin of 1.63% compared to Repay's net margin of -35.79%. V2X's return on equity of 15.28% beat Repay's return on equity.

Company Net Margins Return on Equity Return on Assets
V2X1.63% 15.28% 5.01%
Repay -35.79%8.89%4.31%

V2X has higher revenue and earnings than Repay. Repay is trading at a lower price-to-earnings ratio than V2X, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
V2X$4.32B0.41$34.68M$2.2025.35
Repay$310.37M1.35-$10.16M-$1.26-3.64

Summary

V2X beats Repay on 12 of the 17 factors compared between the two stocks.

Get Repay News Delivered to You Automatically

Sign up to receive the latest news and ratings for RPAY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RPAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RPAY vs. The Competition

MetricRepayFinancial Transaction Services IndustryBusiness SectorNASDAQ Exchange
Market Cap$419.24M$33.41B$94.72T$10.26B
Dividend YieldN/A2.30%2.85%4.69%
P/E Ratio-3.6436.6825.9426.60
Price / Sales1.3547.4574,762.31178.23
Price / Cash2.4517.0531.0862.20
Price / Book0.527.79185,976.796.54
Net Income-$10.16M$1.11B$196.66M$275.87M
7 Day Performance-12.57%-4.82%3,926,812.79%-1.32%
1 Month Performance-18.90%1.70%3,941,497.67%5.24%
1 Year Performance-41.08%37.81%7,791,627.70%31.56%

Repay Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RPAY
Repay
3.3506 of 5 stars
$4.59
-5.4%
$7.22
+57.3%
-39.2%$419.24M$310.37M-3.64580Positive News
VVX
V2X
4.1504 of 5 stars
$60.36
+1.2%
$63.73
+5.6%
-3.1%$1.89B$4.32B27.4416,100Positive News
Analyst Forecast
LZ
LegalZoom.com
3.0083 of 5 stars
$10.08
-1.6%
$10.83
+7.5%
+52.2%$1.85B$681.88M63.001,220Analyst Forecast
RAMP
LiveRamp
4.7586 of 5 stars
$28.00
+2.2%
$40.83
+45.8%
+14.0%$1.80B$764.44M127.281,300News Coverage
Analyst Forecast
ALIT
Alight
4.5343 of 5 stars
$3.24
-0.9%
$8.75
+170.1%
-57.4%$1.76B$2.33B-1.479,500Analyst Forecast
FIVN
Five9
4.3057 of 5 stars
$23.09
+1.3%
$37.88
+64.1%
-21.9%$1.76B$1.11B256.583,073Analyst Forecast
Options Volume
ACVA
ACV Auctions
N/A$9.69
-4.2%
N/AN/A$1.74B$637.16M-24.852,900
OLO
OLO
1.7993 of 5 stars
$10.26
flat
$10.17
-0.9%
N/A$1.74B$314.33M28.50710
FLYW
Flywire
2.9941 of 5 stars
$13.47
-0.6%
$13.54
+0.5%
-19.4%$1.66B$492.14M269.401,250Analyst Forecast
ASTH
Astrana Health
4.0111 of 5 stars
$28.87
+0.4%
$50.50
+74.9%
-47.8%$1.61B$2.42B56.611,900Analyst Forecast
GDRX
GoodRx
4.131 of 5 stars
$4.58
+1.1%
$5.80
+26.6%
-34.0%$1.57B$792.32M45.80950Trending News
Analyst Forecast

Related Companies and Tools


This page (NASDAQ:RPAY) was last updated on 10/10/2025 by MarketBeat.com Staff
From Our Partners